This page shows the publications co-authored by Gregory Piazza and Shelley Hurwitz.
Stroke risk factors and outcomes among hospitalized women with atrial fibrillation. J Thromb Thrombolysis. 2021 Nov; 52(4):1023-1031.
Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19. J Am Coll Cardiol. 2020 11 03; 76(18):2060-2072.
Patients with perceived high-bleeding risk and computerized decision support for stroke prevention in atrial fibrillation: an AF-ALERT substudy : Piazza: outcomes of high-bleeding risk AF patients. J Thromb Thrombolysis. 2021 Jul; 52(1):281-290.
Alert-based computerized decision support for high-risk hospitalized patients with atrial fibrillation not prescribed anticoagulation: a randomized, controlled trial (AF-ALERT). Eur Heart J. 2020 03 07; 41(10):1086-1096.
Anticoagulation and Mortality Rates among Hospitalized Patients with Atrial Fibrillation. TH Open. 2018 Jan; 2(1):e33-e38.
Fatal warfarin-associated intracranial hemorrhage in atrial fibrillation inpatients. J Thromb Thrombolysis. 2019 Feb; 47(2):331-335.
Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels. Am J Med. 2012 Jan; 125(1):44-9.
Multi-screen electronic alerts to augment venous thromboembolism prophylaxis. Thromb Haemost. 2010 Feb; 103(2):312-7.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.